Skip to main content
PYC THERAPEUTICS LIMITED logo

PYC THERAPEUTICS LIMITED — Investor Relations & Filings

Ticker · PYC ISIN · AU000000PYC7 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,297 across all filing types
Latest filing 2010-11-29 Declaration of Voting R…
Country AU Australia
Listing ASX PYC

About PYC THERAPEUTICS LIMITED

https://pyctx.com/

PYC Therapeutics Limited is a clinical-stage company focused on developing precision medicines for patients with rare genetic diseases. The company utilizes a proprietary drug delivery platform that combines naturally derived cell-penetrating peptides with antisense oligonucleotides to create RNA-based therapeutics. This platform is designed to overcome the challenges of delivering large therapeutic molecules into target cells, particularly within the eye and central nervous system. PYC's primary pipeline includes VP-001, a candidate for Retinitis Pigmentosa type 11, and PYC-001, targeting Autosomal Dominant Optic Atrophy. Additionally, the company is advancing programs for Polycystic Kidney Disease. By leveraging its delivery technology, PYC aims to address the underlying genetic causes of diseases that currently lack effective treatment options.

Recent filings

Filing Released Lang Actions
Results of Meeting 2 pages ?Kb
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'GENERAL MEETING RESULTS' and provides detailed voting outcomes for resolutions passed at the Annual General Meeting (AGM) of Phylogica Limited held on 30 November 2010. It includes vote counts for each resolution, indicating it is an official announcement of shareholder voting results. The document length is short (1995 characters), and it does not contain the full AGM materials or presentations, only the results. According to the classification rules, such documents reporting official voting outcomes at a general meeting should be classified as Declaration of Voting Results & Voting Rights Announcements (DVA).
2010-11-29 English
AGM presentation 32 pages ?Kb
AGM Information Classification · 95% confidence The document is titled 'Phylogica AGM November 2010' and contains detailed presentations including introductions of speakers, highlights of the year, financials, business model explanations, partnerships, and market analysis. The date and the nature of the content strongly indicate this is material prepared for an Annual General Meeting (AGM). The document is about 15,000 characters long and consists mainly of presentation slides and speaker notes rather than a formal annual report or financial statements. There is no indication of full financial statements or audit reports, nor is it a transcript of a call or a regulatory filing. The content is consistent with AGM presentation materials shared with shareholders during the meeting.
2010-11-29 English
MedImmune drug discovery activities commence 2 pages ?Kb
Capital/Financing Update Classification · 95% confidence The document is a company announcement dated 2 November 2010 from Phylogica Limited regarding the commencement of antimicrobial peptide discovery under a licensing agreement with MedImmune. It details the agreement terms, payments received, and future milestones. There are no financial statements, regulatory filings, or detailed financial reports included. The document is an update on a licensing and research collaboration, which fits the category of Capital/Financing Update (CAP) as it discusses funding received and future payments related to the agreement. The document length is under 5,000 characters and does not contain a report or financial statements, so it is not an Annual Report or Interim Report. It is not a Regulatory Filing or Report Publication Announcement since it contains substantive information about the agreement and payments. Therefore, the best classification is Capital/Financing Update (CAP).
2010-11-01 English
Appendix 4C - quarterly 6 pages ?Kb
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Appendix 4C Quarterly Report - 30 September 2010' and contains detailed financial data including cash flow statements, payments to directors, financing activities, and reconciliation of cash for the quarter ended 30 September 2010. It is a quarterly report with substantive financial data and analysis, not merely an announcement or certification. The presence of detailed financial tables and notes confirms it is a comprehensive interim/quarterly financial report. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q1 2010
2010-10-28 English
Notice of Annual General Meeting/Proxy Form 24 pages ?Kb
AGM Information Classification · 100% confidence The document is titled 'NOTICE OF ANNUAL GENERAL MEETING' and includes detailed information about the time, place, agenda, and resolutions to be voted on at the AGM. It contains proxy voting instructions, explanatory statements for resolutions, and references to the annual financial report but does not contain the financial report itself. The document is about the meeting logistics and shareholder voting matters, typical of AGM notices. It is not the annual report or financial statements themselves, nor is it a voting results announcement. The length is substantial but the content is clearly a notice and explanatory material for the AGM. Therefore, the document fits the category of AGM Information (AGM-R).
2010-10-27 English
Annual Report to shareholders 64 pages ?Kb
Annual Report Classification · 100% confidence The document is titled 'annual report phylogica limited' and contains detailed sections typical of an annual report, including Chairman's report, Research and development update, Directors' report, Auditor's independence declaration, financial statements (comprehensive income, financial position, cash flows), notes to financial statements, Directors' declaration, and Corporate governance statement. The content discusses company strategy, partnerships, financial performance, management changes, and outlook, all consistent with a comprehensive yearly report. The document length is 15,000 characters, indicating it is a full report rather than a brief announcement. There is no indication that this is merely an announcement of a report or a certification. Therefore, this document fits the definition of an Annual Report (10-K).
2010-10-27 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.